David Crispino Volpe, Chief Financial Officer at AdvanSource Biomaterials Corp (ASNB), bought 25,000 shares at $0.05 ($1K) on 2012-11-19, disclosed to the SEC on 2012-11-21.
Open-market purchase of $1k ASNB by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.04 | 15,000 | $600 | 54.5% |
| 2 | $0.05 | 10,000 | $500 | 45.5% |
| Total | $0.04 avg | 25,000 | $1K | 100% |
| Filing → |
| ASNB | BUY | 2012-12-10 | $300 | — | Filing → |
| ASNB | BUY | 2012-12-04 | $150 | — | Filing → |
| ASNB | BUY | 2012-12-03 | $200 | — | Filing → |